You can buy or sell SRRA and other stocks, options, ETFs, and crypto commission-free!
Sierra Oncology, Inc. Common Stock, also called Sierra Oncology, is a clinical stage drug development company of therapeutics for the treatment of patients with cancer. Read More It engages in the business of researching, developing, and commercializing therapies for the treatment of patients with cancer. The company was founded on May 8, 2003 and is headquartered in Vancouver, Canada.
Vancouver, British Columbia
52 Week High
52 Week Low
Yahoo FinanceMay 8
Sierra Oncology Reports First Quarter 2019 Results
Momelotinib regulatory pathway clarity anticipated in Q2 2019 - - SRA737 Phase 1/2 preliminary clinical data anticipated at the 2019 ASCO Annual Meeting - VANCOUVER , May 8, 2019 /CNW/ - Sierra Oncology, Inc. ("Sierra Oncology") (SRRA), a clinical stage drug development company focused on advancing targeted therapeutics for the treatment of patients with unmet needs in hematology and oncology, today reported its financial and operational results for the first quarter ended March 31, 2019 . "During the fi...
PR NewswireMay 6
Sierra Oncology to Attend Two Investor Conferences in May
VANCOUVER, May 6, 2019 /PRNewswire/ - Sierra Oncology, Inc. (SRRA), a clinical stage drug development company focused on advancing targeted therapeutics for the treatment of patients with significant unmet needs in hematology and oncology, today announced that members of its senior management team will be attending the SunTrust Robinson Humphrey 5th Annual Life Sciences Conference in New York on May 8th, and the Oppenheimer Oncology Insight Summit in New York on May 16th. Sun Trust Robinson Humphrey 5th An...
Expected Aug 8, Pre-Market